Skip to main content
Erschienen in: Quality of Life Research 11/2017

03.07.2017 | Brief Communication

Reduction of quality-adjusted life years (QALYs) in patients with premenstrual dysphoric disorder (PMDD)

verfasst von: Kazuo Yamada, Eiichiro Kamagata

Erschienen in: Quality of Life Research | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Premenstrual dysphoric disorder (PMDD) refers to the depression that occurs during the premenstrual phase and remits soon after the onset of menses. It affects the quality of life (QOL) of patients with PMDD. Therefore, this preliminary survey from chart recordings aimed to understand the symptom appearance and QOL reduction patterns in patients with PMDD, and to examine the extent of the loss of their quality-adjusted life years (QALYs).

Methods

Participants were 66 untreated female patients with PMDD. Data on symptom appearance and QOL reduction during the menstrual cycle, and the EuroQoL-5D (EQ-5D) scores during the premenstrual phase and immediately after the completion of a menstrual period were collected.

Results

The mean EQ-5D score of the 66 patients with PMDD was 0.795 ± 0.120 (range 0.362–0.949), indicating that their expected mean loss of QALYs was about 0.14 years.

Conclusions

If untreated, PMDD is expected to cause a mean loss of QALYs of about 0.14 years. However, on accounting for the period from disease development to menopause, and subtracting the menstruation-free periods such as pregnancy and breastfeeding, patients with untreated PMDD are expected to experience a QALY loss of about 3 years during their lifetime.
Literatur
1.
Zurück zum Zitat American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington: American Psychiatric Press.CrossRef American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington: American Psychiatric Press.CrossRef
2.
Zurück zum Zitat Johnson, S. R. (2004). Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: A clinical primer for practitioners. Obstetrics and Gynecology, 104(4), 845–859.CrossRefPubMed Johnson, S. R. (2004). Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: A clinical primer for practitioners. Obstetrics and Gynecology, 104(4), 845–859.CrossRefPubMed
3.
Zurück zum Zitat Rapkin, A. J., & Winer, S. A. (2009). Premenstrual syndrome and premenstrual dysphoric disorder: Quality of life and burden of illness. Expert Review of Pharmacoeconomics & Outcomes Research, 9(2), 157–170.CrossRef Rapkin, A. J., & Winer, S. A. (2009). Premenstrual syndrome and premenstrual dysphoric disorder: Quality of life and burden of illness. Expert Review of Pharmacoeconomics & Outcomes Research, 9(2), 157–170.CrossRef
4.
Zurück zum Zitat Hall, E., & Steiner, M. (2015). Psychiatric symptoms and disorders associated with reproductive cyclicity in women: Advances in screening tools. Women’s health, 11(3), 397–415.PubMed Hall, E., & Steiner, M. (2015). Psychiatric symptoms and disorders associated with reproductive cyclicity in women: Advances in screening tools. Women’s health, 11(3), 397–415.PubMed
5.
Zurück zum Zitat Tajima, R., Kondo, M., Kai, H., Saito, C., Okada, M., Takahashi, H., et al. (2010). Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D). Clinical and Experimental Nephrology, 14(4), 340–348.CrossRefPubMed Tajima, R., Kondo, M., Kai, H., Saito, C., Okada, M., Takahashi, H., et al. (2010). Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D). Clinical and Experimental Nephrology, 14(4), 340–348.CrossRefPubMed
6.
Zurück zum Zitat Saleem, F., Hassali, M. A., & Shafie, A. A. (2014). A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expectations, 17(3), 388–395.CrossRefPubMed Saleem, F., Hassali, M. A., & Shafie, A. A. (2014). A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expectations, 17(3), 388–395.CrossRefPubMed
7.
Zurück zum Zitat Yang, F., Griva, K., Lau, T., Vathsala, A., Lee, E., Ng, H. J., et al. (2015). Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore. Quality of Life Research, 24(9), 2163–2171.CrossRefPubMed Yang, F., Griva, K., Lau, T., Vathsala, A., Lee, E., Ng, H. J., et al. (2015). Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore. Quality of Life Research, 24(9), 2163–2171.CrossRefPubMed
8.
Zurück zum Zitat Subramaniam, M., Abdin, E., Vaingankar, J. A., Nan, L., Heng, D., McCrone, P., et al. (2013). Impact of psychiatric disorders and chronic physical conditions on health-related quality of life: Singapore Mental Health Study. Journal of Affective Disorders, 147(1–3), 325–330.CrossRefPubMed Subramaniam, M., Abdin, E., Vaingankar, J. A., Nan, L., Heng, D., McCrone, P., et al. (2013). Impact of psychiatric disorders and chronic physical conditions on health-related quality of life: Singapore Mental Health Study. Journal of Affective Disorders, 147(1–3), 325–330.CrossRefPubMed
9.
Zurück zum Zitat Saarni, S. I., Suvisaari, J., Sintonen, H., Pirkola, S., Koskinen, S., Aromaa, A., et al. (2007). Impact of psychiatric disorders on health-related quality of life: General population survey. British Journal of Psychiatry, 190, 326–332.CrossRefPubMed Saarni, S. I., Suvisaari, J., Sintonen, H., Pirkola, S., Koskinen, S., Aromaa, A., et al. (2007). Impact of psychiatric disorders on health-related quality of life: General population survey. British Journal of Psychiatry, 190, 326–332.CrossRefPubMed
10.
Zurück zum Zitat Penner-Goeke, K., Henriksen, C. A., Chateau, D., Latimer, E., Sareen, J., & Katz, L. Y. (2015). Reductions in quality of life associated with common mental disorders: Results from a nationally representative sample. Journal of Clinical Psychiatry, 76(11), 1506–1512.CrossRefPubMed Penner-Goeke, K., Henriksen, C. A., Chateau, D., Latimer, E., Sareen, J., & Katz, L. Y. (2015). Reductions in quality of life associated with common mental disorders: Results from a nationally representative sample. Journal of Clinical Psychiatry, 76(11), 1506–1512.CrossRefPubMed
11.
Zurück zum Zitat American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, fourth edition, text revision; DSM-IV-TR. Washington: American Psychiatric Press.CrossRef American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, fourth edition, text revision; DSM-IV-TR. Washington: American Psychiatric Press.CrossRef
12.
Zurück zum Zitat EuroQoL Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef EuroQoL Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
13.
Zurück zum Zitat Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: the case of Japan. Health Economics, 11(4), 341–353.CrossRefPubMed Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: the case of Japan. Health Economics, 11(4), 341–353.CrossRefPubMed
14.
Zurück zum Zitat Shiroiwa, T., Fukuda, T., Ikeda, S., Igarashi, A., Noto, S., Saito, S., et al. (2016). Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Quality of Life Research, 25(3), 707–719.CrossRefPubMed Shiroiwa, T., Fukuda, T., Ikeda, S., Igarashi, A., Noto, S., Saito, S., et al. (2016). Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Quality of Life Research, 25(3), 707–719.CrossRefPubMed
15.
Zurück zum Zitat Shah, N. R., Jones, J. B., Aperi, J., Shemtov, R., Karne, A., & Borenstein, J. (2008). Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: A meta-analysis. Obstetrics and Gynecology, 111(5), 1175–1182.CrossRefPubMedPubMedCentral Shah, N. R., Jones, J. B., Aperi, J., Shemtov, R., Karne, A., & Borenstein, J. (2008). Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: A meta-analysis. Obstetrics and Gynecology, 111(5), 1175–1182.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Steiner, M., Pearlstein, T., Cohen, L. S., Endicott, J., Kornstein, S. G., Roberts, C., et al. (2006). Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. Journal of Women’s Health, 15(1), 57–69.CrossRefPubMed Steiner, M., Pearlstein, T., Cohen, L. S., Endicott, J., Kornstein, S. G., Roberts, C., et al. (2006). Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. Journal of Women’s Health, 15(1), 57–69.CrossRefPubMed
Metadaten
Titel
Reduction of quality-adjusted life years (QALYs) in patients with premenstrual dysphoric disorder (PMDD)
verfasst von
Kazuo Yamada
Eiichiro Kamagata
Publikationsdatum
03.07.2017
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 11/2017
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1642-1

Weitere Artikel der Ausgabe 11/2017

Quality of Life Research 11/2017 Zur Ausgabe